Egl-9 Family Hypoxia Inducible Factor 3 (EGLN3) Peptide
Aperçu rapide pour Egl-9 Family Hypoxia Inducible Factor 3 (EGLN3) Peptide (ABIN8099497)
Antigène
Source
Application
-
-
Fonction
- EGLN3 Peptide
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Commentaires
-
This is a synthetic peptide designed for use in combination with anti-EGLN3 antibody ( ARP52402_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- EGLN3 (Egl-9 Family Hypoxia Inducible Factor 3 (EGLN3))
-
Sujet
-
Background Information: EGLN3 catalyzes the post-translational formation of 4-hydroxyproline in hypoxia-inducible factor (HIF) alpha proteins. It hydroxylates HIF-1 alpha at 'Pro-564', and HIF-2 alpha. EGLN3 functions as a cellular oxygen sensor and, under normoxic conditions, targets HIF through the hydroxylation for proteasomal degradation via the von Hippel-Lindau ubiquitination complex. It may play a role in cell growth regulation in muscle cells and in apoptosis in neuronal tissue. EGLN3 promotes cell death through a caspase-dependent mechanism.
Alternative Symbols: FLJ21620, HIFPH3, MGC125998, MGC125999, PHD3
-
Poids moléculaire
- 27kDa
-
ID gène
- 112399
-
NCBI Accession
- NP_071356
-
UniProt
- Q9H6Z9
Antigène
-